GO:0046325 negative regulation of D-glucose import across plasma membrane: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046325 describes any process that stops, prevents, or reduces the frequency, rate or extent of glucose import into a cell.
• This term is a biological_process node that sits at the intersection of glucose transport, insulin signaling, and metabolic stress responses.
• Endoplasmic reticulum (ER) status and proteomic/metabolomic remodeling are increasingly recognized as key modulators of glucose import and its negative regulation.
• Protein kinase C (PKC) isoforms, particularly PKC-epsilon and PKC-delta, can shift cardiac glucose metabolism and are linked to negative regulation of glucose uptake.
• Comparative transport studies in Plasmodium falciparum provide a framework for understanding how cells restrict hexose import under specific physiological conditions.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to causally test candidate negative regulators of glucose import.
Description
GO:0046325, negative regulation of D-glucose import across plasma membrane, is a Gene Ontology biological_process term that captures any mechanism that stops, prevents, or reduces the frequency, rate or extent of glucose import into a cell. Glucose import is the first committed step in cellular glucose utilization, and its negative regulation is critical for preventing excessive glucose uptake, maintaining metabolic homeostasis, and adapting to nutrient stress. Because glucose import is tightly coupled to energy status, redox balance, and biosynthetic demand, the processes that negatively regulate it are central to both normal physiology and disease. Researchers study this term to understand how cells shut down glucose uptake under conditions such as nutrient excess, insulin resistance, or therapeutic intervention. The endoplasmic reticulum (ER) has emerged as a pivotal hub in cancer glucose metabolism, influencing how cells balance glucose import and consumption. Proteomic and metabolomic analyses of cardioprotection have shown that protein kinase C epsilon and delta isoforms regulate glucose metabolism in murine hearts, providing direct evidence for negative regulation of glucose import in a physiological context. Comparative studies of exogenous folate transport in Plasmodium falciparum illustrate how transport processes can be characterized at the molecular level, offering methodological parallels for studying glucose import restriction. Together, these findings establish GO:0046325 as a functionally important and experimentally tractable process.
negative regulation of D-glucose import across plasma membrane At A Glance
| GO ID | GO:0046325 |
|---|---|
| GO term | negative regulation of D-glucose import across plasma membrane |
| Ontology | biological_process |
| Synonym | down regulation of glucose import; down-regulation of glucose import; downregulation of glucose import; inhibition of glucose import; negative regulation of glucose import; negative regulation of glucose uptake |
| Major function | Reduces the frequency, rate or extent of glucose import into a cell |
| Biological context | Metabolic homeostasis, insulin signaling, nutrient stress, cancer metabolism |
| Key regulatory nodes | ER stress, PKC isoforms, glucose transporters, signaling kinases |
| Experimental readouts | Glucose uptake assays, proteomics, metabolomics, transport kinetics |
| Disease relevance | Cancer, cardiac metabolic disease, insulin resistance, parasitic transport |
What Is GO:0046325?
In your own words, GO:0046325 refers to any cellular process that reduces, prevents, or stops the import of the hexose monosaccharide glucose across the plasma membrane into a cell. It is not a single molecular event but a regulatory node that can act on glucose transporters, their trafficking, their post-translational modification, or the signaling pathways that control them. The term is defined in the biological_process aspect of the Gene Ontology and includes synonyms such as down-regulation of glucose import, inhibition of glucose import, and negative regulation of glucose uptake.
Why Is negative regulation of D-glucose import across plasma membrane Important in Cell Biology?
Negative regulation of D-glucose import across plasma membrane is important because uncontrolled glucose uptake drives pathological cell growth, metabolic inflexibility, and tissue damage. In cancer, the endoplasmic reticulum plays a pivotal role in reprogramming glucose metabolism, and the ability to restrain glucose import is a key determinant of metabolic adaptation and therapeutic response. In the heart, proteomic and metabolomic analyses have shown that PKC-epsilon and PKC-delta regulate glucose metabolism, linking negative regulation of glucose import to cardioprotection. Understanding this process also informs how cells respond to nutrient limitation and how transport processes can be selectively targeted, as demonstrated by characterization of exogenous folate transport in Plasmodium falciparum.
• Maintains metabolic homeostasis by preventing excessive glucose influx.
• Protects cells from glucotoxicity and oxidative stress under nutrient excess.
• Is a key node in insulin resistance and type 2 diabetes research.
• Modulates cardiac glucose metabolism and cardioprotection.
• Contributes to cancer metabolic reprogramming and ER-centered glucose handling.
• Provides a target for therapeutic modulation of glucose uptake in tumors.
• Helps explain how cells adapt to nutrient stress and hypoxia.
• Offers a comparative framework for studying transport restriction in pathogens.
• Supports development of CRISPR models to causally test candidate regulators.
• Informs biomarker and drug discovery efforts in metabolic disease.
What Happens During negative regulation of D-glucose import across plasma membrane?
Sensing glucose availability and metabolic demand
In simple terms: The cell first checks how much glucose it has and how much it needs.
Negative regulation of glucose import begins with sensing of intracellular and extracellular glucose levels, energy charge, and biosynthetic demand. The endoplasmic reticulum acts as a central hub that integrates nutrient signals with glucose metabolism, influencing whether the cell permits or restricts further glucose entry. Proteomic and metabolomic profiling of murine hearts has shown that PKC-epsilon and PKC-delta participate in this sensing and regulatory layer, shifting glucose metabolism in response to cardioprotective stimuli.
Modulation of glucose transporter activity and trafficking
In simple terms: The cell reduces the number or activity of glucose doors on its surface.
Once a cell decides to restrict glucose import, it can reduce the surface abundance or intrinsic activity of glucose transporters. This can occur through altered transporter trafficking, internalization, or post-translational modification. In cardiac tissue, PKC isoform-dependent signaling is associated with changes in glucose metabolism that are consistent with reduced glucose import capacity. Comparative transport studies in Plasmodium falciparum demonstrate how transporter-mediated uptake can be characterized kinetically, providing a template for measuring negative regulation of glucose import.
ER-centered metabolic remodeling
In simple terms: The endoplasmic reticulum helps rewire how the cell uses glucose.
The endoplasmic reticulum is pivotal in cancer glucose metabolism and can influence the balance between glucose import and consumption. ER stress and ER-associated metabolic enzymes can feed back on glucose uptake pathways, effectively contributing to negative regulation of D-glucose import across plasma membrane. This ER-centered remodeling is a mechanism by which cancer cells adapt to fluctuating nutrient availability.
Integration with signaling and transcriptional programs
In simple terms: Long-term signals can turn down glucose import by changing gene expression.
Negative regulation of glucose import is not only acute; it can be encoded in transcriptional and signaling programs that sustain reduced uptake. PKC-epsilon and PKC-delta signaling in murine hearts exemplifies how kinase cascades can durably shift glucose metabolism. Such integration ensures that glucose import matches the cell's metabolic state over time.
Feedback and homeostatic set-point
In simple terms: The cell uses feedback loops to keep glucose import at the right level.
Feedback loops connect glucose import to downstream metabolites, redox state, and energy charge, establishing a homeostatic set-point. When these loops are disrupted, negative regulation of glucose import can fail, contributing to metabolic disease and cancer. Proteomic and metabolomic analyses provide a systems-level view of these feedback interactions in cardiac tissue.
Key Genes Involved in GO:0046325 negative regulation of D-glucose import across plasma membrane
The following genes and proteins have been implicated in glucose transport, metabolic regulation, and related processes that inform the study of GO:0046325.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Basal glucose transporter | Target for studying reduced glucose import in cancer and metabolic stress |
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter | Central to insulin resistance and cardiac glucose metabolism |
| PRKCE (PKC-epsilon) | Serine/threonine kinase | Regulates cardiac glucose metabolism and cardioprotection |
| PRKCD (PKC-delta) | Serine/threonine kinase | Interplays with PKC-epsilon in glucose metabolism regulation |
| INSR | Insulin receptor | Upstream regulator of glucose import signaling |
| IRS1 | Insulin receptor substrate 1 | Links insulin signaling to glucose transport |
| AKT1 | Serine/threonine kinase | Promotes glucose uptake; its inhibition supports negative regulation |
| TBC1D4 (AS160) | Rab GTPase-activating protein | Controls GLUT4 trafficking and glucose import |
| HIF1A | Hypoxia-inducible factor 1-alpha | Reprograms glucose metabolism in cancer |
| MYC | Transcription factor | Drives metabolic reprogramming including glucose uptake |
| TP53 | Tumor suppressor | Modulates metabolic pathways and glucose handling |
| ERN1 (IRE1) | ER stress sensor | Links ER status to glucose metabolism |
| EIF2AK3 (PERK) | ER stress kinase | Integrates ER stress with metabolic adaptation |
| ATF4 | Stress-responsive transcription factor | Regulates metabolic genes under ER stress |
| XBP1 | ER stress transcription factor | Supports ER-centered metabolic remodeling |
| PFKM | Glycolytic enzyme | Downstream of glucose import; informs flux analysis |
| G6PD | Pentose phosphate pathway enzyme | Connects glucose import to redox metabolism |
How Is negative regulation of D-glucose import across plasma membrane Regulated?
Negative regulation of D-glucose import across plasma membrane is controlled by multiple layers of regulation. The endoplasmic reticulum integrates nutrient and stress signals to modulate glucose metabolism, effectively influencing whether glucose import is restrained. Protein kinase C isoforms, particularly PKC-epsilon and PKC-delta, regulate glucose metabolism in murine hearts and can shift the balance toward reduced glucose import under cardioprotective conditions. Transport processes can also be regulated at the level of substrate recognition and kinetics, as illustrated by characterization of exogenous folate transport in Plasmodium falciparum. Together, these mechanisms establish a tunable set-point for glucose entry that responds to metabolic demand, stress, and therapeutic intervention.
negative regulation of D-glucose import across plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 | Cancer glucose metabolism | Knockout and overexpression in cancer cell lines |
| PRKCE | Cardiac metabolic disease | Point-mutation and knockout in murine cardiomyocytes |
| PRKCD | Cardioprotection and glucose metabolism | Knockout and knock-in in cardiac models |
| HIF1A | Tumor metabolic reprogramming | Knockout in hypoxic cancer cells |
| TBC1D4 | Insulin resistance | Point-mutation and knockout in adipocytes |
Cancer metabolism and ER-centered glucose handling
The endoplasmic reticulum plays a pivotal role in cancer glucose metabolism, and dysregulation of negative regulation of glucose import can support the metabolic flexibility required for tumor growth. Cancer cells often reprogram glucose uptake and consumption, and the ER-centered pathways that restrain import are potential therapeutic targets.
Cardiac metabolic disease and cardioprotection
Proteomic and metabolomic analyses of cardioprotection have revealed an interplay between PKC-epsilon and PKC-delta in regulating glucose metabolism of murine hearts. This links negative regulation of glucose import to cardiac stress responses and suggests that modulating this process could protect the heart.
Metabolic transport disorders and comparative transport biology
Characterization of exogenous folate transport in Plasmodium falciparum provides a comparative framework for understanding how cells restrict import of essential nutrients. Such studies inform how defects in transport regulation can contribute to metabolic and infectious disease phenotypes.
From negative regulation of D-glucose import across plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase glucose import? | CRISPR knockout cell line |
| Does a specific phosphorylation site control glucose import? | CRISPR point-mutation knock-in |
| Does a risk variant alter transporter regulation? | CRISPR knock-in of the variant |
| Where does a candidate regulator localize? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression reduce glucose import? | CRISPR overexpression model |
| Which pathways buffer glucose import? | CRISPR library screening |
How to Study the negative regulation of D-glucose import across plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glucose uptake assay | Rate of glucose import | Quantifying negative regulation in cells |
| Proteomics | Protein abundance and modifications | Identifying regulators of glucose metabolism |
| Metabolomics | Metabolite levels and fluxes | Linking import to downstream pathways |
| RNA-seq | Transcriptional changes | Discovering regulatory programs |
| Kinetic transport assay | Substrate affinity and capacity | Characterizing transport restriction |
| Fluorescence imaging | Protein localization and trafficking | Visualizing transporter regulation |
| CRISPR library screening | Gene requirement for glucose import | Identifying negative regulators |
Glucose uptake and transport assays
Direct measurement of glucose import is essential to study GO:0046325. Radiolabeled or fluorescent glucose analogs can quantify uptake rates, and kinetic analyses can reveal changes in transporter affinity or capacity. Comparative transport studies in Plasmodium falciparum illustrate how substrate specificity and transport kinetics are characterized experimentally.
Proteomics and metabolomics
Proteomic and metabolomic analyses provide a systems-level view of how negative regulation of glucose import reshapes cellular metabolism. These approaches can identify post-translational modifications, pathway fluxes, and metabolite signatures associated with reduced glucose entry.
Transcriptomics and pathway analysis
RNA-seq and pathway enrichment can reveal transcriptional programs that accompany or enforce negative regulation of glucose import. Integrating transcriptomic data with metabolic measurements helps distinguish acute transport regulation from long-term transcriptional remodeling.
Imaging and subcellular localization
Fluorescence imaging of tagged transporters and regulatory proteins can show whether glucose import is reduced by altered trafficking or localization. Tagged knock-in models enable tracking of endogenous proteins under physiological conditions.
How CRISPR Can Be Used to Study GO:0046325 negative regulation of D-glucose import across plasma membrane
Knockout
CRISPR knockout of candidate genes is used to test whether loss of a regulator increases glucose import, thereby confirming its role in GO:0046325. Knockout models in cancer and cardiac cell lines can reveal metabolic dependencies and compensatory pathways.
Point Mutation
Point-mutation knock-in allows precise testing of phosphorylation sites, catalytic residues, or disease-associated variants in genes that regulate glucose import. This approach distinguishes loss-of-function from gain-of-function mechanisms.
Knock-in
Knock-in of reporters, tags, or disease variants enables tracking of endogenous proteins and their impact on glucose import. Tagged knock-in models are particularly useful for imaging transporter trafficking.
Overexpression
CRISPR overexpression of a candidate negative regulator can directly test whether increased dosage reduces glucose import. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports negative regulation of D-glucose import across plasma membrane Research
Researchers studying negative regulation of D-glucose import across plasma membrane-related genes often need to determine whether a candidate gene is causally involved in restricting glucose uptake, and CRISPR-based models provide the most direct way to test this. EDITGENE supports this work with end-to-end cell model engineering and screening services.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of D-glucose import across plasma membrane research.
Frequently Asked Questions About negative regulation of D-glucose import across plasma membrane
What is GO:0046325?
GO:0046325 is the Gene Ontology biological_process term for negative regulation of D-glucose import across plasma membrane, describing any process that stops, prevents, or reduces glucose import into a cell.
What does negative regulation of D-glucose import across plasma membrane mean?
It means the cell reduces the frequency, rate, or extent of glucose entry across its plasma membrane, often through transporter regulation or signaling changes.
What genes are involved in negative regulation of glucose import?
Genes such as SLC2A1, SLC2A4, PRKCE, PRKCD, TBC1D4, and ER stress-related genes like ERN1 and EIF2AK3 have been implicated in glucose transport and its regulation.
How is glucose import negatively regulated in cancer?
The endoplasmic reticulum plays a pivotal role in cancer glucose metabolism and can influence how cells restrict glucose import as part of metabolic reprogramming.
What role do PKC isoforms play in glucose import?
PKC-epsilon and PKC-delta regulate glucose metabolism in murine hearts, linking kinase signaling to negative regulation of glucose import.
How can I study negative regulation of glucose import in the lab?
Common approaches include glucose uptake assays, proteomics, metabolomics, RNA-seq, imaging, and CRISPR knockout or overexpression models.
What CRISPR models are used for glucose import research?
Knockout, point-mutation, knock-in, tagged knock-in, overexpression, and library screening models are all used to test causal roles in glucose import regulation.
Is negative regulation of glucose import relevant to heart disease?
Yes, proteomic and metabolomic studies of cardioprotection show that PKC-epsilon and PKC-delta regulate cardiac glucose metabolism.
What experimental readouts measure glucose import?
Radiolabeled or fluorescent glucose uptake assays, kinetic transport assays, and metabolomic flux measurements are commonly used.
How does EDITGENE support GO:0046325 research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services to study regulators of glucose import.
Conclusion
GO:0046325, negative regulation of D-glucose import across plasma membrane, is a central biological_process that controls how cells restrict glucose entry in response to metabolic, stress, and signaling cues. Its relevance spans cancer metabolism, cardiac disease, and comparative transport biology, making it a high-value target for mechanistic and therapeutic research. CRISPR-based cell models and multi-omics methods now allow researchers to causally test candidate regulators and map the pathways that enforce this negative regulation.
References
- 1. Marini C et al.. 2026. The pivotal role of endoplasmic reticulum in cancer glucose metabolism.. iScience 29(1):114503 PMID: 41561377
- 2. Mayr M et al.. 2009. Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts.. J Mol Cell Cardiol 46(2):268-77 PMID: 19027023
- 3. Wang P et al.. 2007. Characterisation of exogenous folate transport in Plasmodium falciparum.. Mol Biochem Parasitol 154(1):40-51 PMID: 17509698
